[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Companys announcement dated 27 August 2004. The accumulated premium inco]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Companys announcement dated 27 August 2004. The accumulated premium inco]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[Registration No. 333-221868 PROSPECTUS SUPPLEMENT (to Prospectus dated December 8, 2017) 2,359,272 Shares of Common Stock Securities Act Our common stock is listed on the Nasdaq Capital Market and traded under the symbol “CREG.” The last reported sale price of our common stock on the Nasdaq Capital ]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[Registration No. 333-221868 PROSPECTUS SUPPLEMENT (to Prospectus dated December 8, 2017) 2,359,272 Shares of Common Stock Securities Act Our common stock is listed on the Nasdaq Capital Market and traded under the symbol “CREG.” The last reported sale price of our common stock on the Nasdaq Capital ]
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 DATE OF BOARD MEETING Aluminum Corporation of China Limited Date April 15, 2019 By About the Company Our contact information of this release is: * Business address: No]
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
